Saeed Mohamed, Jacob Stefan, Sandjo Louis P, Sugimoto Yoshikazu, Khalid Hassan E, Opatz Till, Thines Eckhard, Efferth Thomas
Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University of Mainz Mainz, Germany.
Institut für Biotechnologie und Wirkstoff-Forschung Kaiserslautern, Germany.
Front Pharmacol. 2015 Nov 9;6:267. doi: 10.3389/fphar.2015.00267. eCollection 2015.
Multidrug resistance is a prevailing phenomenon leading to chemotherapy treatment failure in cancer patients. In the current study two known cytotoxic pseudoguaianolide sesquiterpene lactones; neoambrosin (1) and damsin (2) that circumvent MDR were identified. The two cytotoxic compounds were isolated using column chromatography, characterized using 1D and 2D NMR, MS, and compared with literature values. The isolated compounds were investigated for their cytotoxic potential using resazurin assays and thereafter confirmed with immunoblotting and in silico studies. MDR cells overexpressing ABC transporters (P-glycoprotein, BCRP, ABCB5) did not confer cross-resistance toward (1) and (2), indicating that these compounds are not appropriate substrates for any of the three ABC transporters analyzed. Resistance mechanisms investigated also included; the loss of the functions of the TP53 and the mutated EGFR. The HCT116 p53(-/-) cells were sensitive to 1 but resistant to 2. It was interesting to note that resistant cells transfected with oncogenic ΔEGFR exhibited hypersensitivity CS toward (1) and (2) (degrees of resistances were 0.18 and 0.15 for (1) and (2), respectively). Immunoblotting and in silico analyses revealed that 1 and 2 silenced c-Src kinase activity. It was hypothesized that inhibition of c-Src kinase activity may explain CS in EGFR-transfected cells. In conclusion, the significant cytotoxicity of 1 and 2 against different drug-resistant tumor cell lines indicate that they may be promising candidates to treat refractory tumors.
多药耐药是导致癌症患者化疗治疗失败的普遍现象。在当前研究中,鉴定出两种已知的具有细胞毒性的伪愈创木烷型倍半萜内酯;新青蒿素(1)和丹参新醌甲(2),它们可规避多药耐药。使用柱色谱法分离这两种细胞毒性化合物,通过一维和二维核磁共振、质谱对其进行表征,并与文献值进行比较。使用刃天青分析对分离出的化合物的细胞毒性潜力进行研究,随后通过免疫印迹和计算机模拟研究进行确认。过表达ABC转运蛋白(P-糖蛋白、乳腺癌耐药蛋白、ABCB5)的多药耐药细胞对(1)和(2)不产生交叉耐药,这表明这些化合物不是所分析的三种ABC转运蛋白的合适底物。所研究的耐药机制还包括;TP53功能丧失和表皮生长因子受体(EGFR)突变。HCT116 p53(-/-)细胞对1敏感,但对2耐药。有趣的是,转染致癌性ΔEGFR的耐药细胞对(1)和(2)表现出超敏感性((1)和(2)的耐药程度分别为0.18和0.15)。免疫印迹和计算机模拟分析表明,1和2使c-Src激酶活性沉默。据推测,c-Src激酶活性的抑制可能解释了EGFR转染细胞中的超敏感性。总之,1和2对不同耐药肿瘤细胞系具有显著的细胞毒性,表明它们可能是治疗难治性肿瘤的有前景的候选药物。